The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Rise In Market Size Of The Proliferative Diabetic Retinopathy (PDR) Market During The Forecast Period?
The market size for proliferative diabetic retinopathy (pdr) has shown swift expansion in recent years. It is projected to increase from $2.69 billion in 2025 to $2.96 billion in 2026, at a compound annual growth rate (CAGR) of 10.3%. This growth observed in the past can be attributed to the rising prevalence of diabetes mellitus, broader implementation of retinal laser therapies, the expansion of ophthalmology clinics, improved accessibility to eye care services, and the growth in diabetic screening programs.
The proliferative diabetic retinopathy (pdr) market size is projected to experience substantial growth in the coming years. By 2030, it is anticipated to reach $4.49 billion, expanding at a compound annual growth rate (CAGR) of 11.0%. This projected expansion during the forecast period is fueled by several factors, including an escalating demand for long-acting injectable therapies, the rising integration of AI-based retinal diagnostics, the expansion of outpatient ophthalmic procedures, a heightened emphasis on vision preservation strategies, and increased investment in managing diabetic eye disease. Significant trends expected in this period include the growing adoption of anti-VEGF therapies, a surge in the utilization of advanced retinal imaging technologies, an intensified focus on early screening and diagnosis, the broadening scope of minimally invasive surgical interventions, and improved integration of multidisciplinary diabetes care.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp
What Influential Factors Are Boosting The Proliferative Diabetic Retinopathy (PDR) Market Demand?
The increasing incidence of diabetes is projected to stimulate the growth of the proliferative diabetic retinopathy (PDR) market in the coming years. Diabetes, a persistent health condition characterized by elevated blood glucose levels, is the primary cause of proliferative diabetic retinopathy, which can be managed through various treatment approaches to avert further damage to the retina and preserve vision. For instance, according to data from the National Health Service (NHS), a UK government department, published in June 2024, the number of individuals under 40 with diabetes rose from 173,166 in 2022 to 216,440 in 2023. This substantial increase highlights an alarming trend and reflects a rapid surge in diabetes prevalence within younger demographics. Consequently, the rising prevalence of diabetes is a key factor propelling the proliferative diabetic retinopathy (PDR) market.
How Is The Proliferative Diabetic Retinopathy (PDR) Market Structured Across Different Market Segments?
The proliferative diabetic retinopathy (pdr) market covered in this report is segmented –
1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy
2) By Mode of Administration: Injectables, Intravitreal Administration Focus, Other Mode Of Administrations
3) By Application: Hospitals, Clinics, Other Applications
Subsegments:
1) By Anti-VEGF Therapy: Aflibercept, Ranibizumab, Bevacizumab
2) By Intraocular Steroids: Triamcinolone Acetonide, Dexamethasone Implant, Fluocinolone Acetonide
3) By Laser Surgery: Focal Laser Photocoagulation, Panretinal Laser Photocoagulation
4) By Vitrectomy: Pars Plana Vitrectomy, Anterior Vitrectomy
What Trends Are Affecting The Growth Of The Proliferative Diabetic Retinopathy (PDR) Market?
Who Are The Firms Contributing To The Proliferative Diabetic Retinopathy (PDR) Market Ecosystem?
Major companies operating in the proliferative diabetic retinopathy (pdr) market are Johnson And Johnson Limited, F Hoffmann La Roche Ltd, AbbVie Inc, Bayer AG, Novartis AG, Merck KGaA, Kubota Vision Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Mylan NV, Santen Pharmaceutical Co Ltd, Lupin Limited, Genentech Inc, Alcon Inc, Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co Ltd, Bausch And Lomb Corporation, Heidelberg Engineering GmbH, Iridex Corporation, Lumenis Ltd, Optos plc, Zeiss Meditec India Pvt Ltd, Alimera Sciences Inc
Access The Complete Proliferative Diabetic Retinopathy (PDR) Market Report:
Which Region Contributes The Most To The Proliferative Diabetic Retinopathy (PDR) Market?
North America was the largest region in the proliferative diabetic retinopathy market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proliferative diabetic retinopathy (pdr) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Proliferative Diabetic Retinopathy (PDR) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12911&type=smp
Browse Through More Reports Similar to the Global Proliferative Diabetic Retinopathy (PDR) Market 2026, By The Business Research Company
Encephalitis Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report
Dysphagia Management Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/dysphagia-management-global-market-report
Rare Neurological Disease Treatment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
